C CYTOKINETICS

Serial Number 88683650
Registration 6069223
700

Registration Progress

Application Filed
Nov 7, 2019
Under Examination
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered
Jun 2, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-02)
Due: Jun 02, 2026 219 days

Trademark Image

C CYTOKINETICS

Basic Information

Serial Number
88683650
Registration Number
6069223
Filing Date
November 7, 2019
Registration Date
June 2, 2020
Published for Opposition
March 17, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 2, 2020
Registration
Registered
Classes
005

Rights Holder

Cytokinetics, Inc.

03
Address
280 East Grand Avenue
South San Francisco, CA 94080

Ownership History

Cytokinetics, Inc.

Original Applicant
03
South San Francisco, CA

Cytokinetics, Inc.

Owner at Publication
03
South San Francisco, CA

Cytokinetics, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Christopher P. Foley

USPTO Deadlines

Next Deadline
219 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-02)
Due Date
June 02, 2026
Grace Period Ends
December 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Jun 2, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 2, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 12, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 11, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 15, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 14, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 11, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, or skeletal muscle weakness
First Use Anywhere: 20150900
First Use in Commerce: 20150900

Additional Information

Design Mark
The mark consists of stylized "C" with a circle between the opening above the wording "CYTOKINETICS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005